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Abstract: Vitamins are dietary components which are necessary for life. They play a major role in health 
and their deficiency may be linked to symptoms of psychiatric disorders. B vitamins are required for 
proper functioning of the methylation cycle, monoamine oxidase production, DNA synthesis and the repair 
and maintenance of phospholipids. Vitamin B deficiency could influence memory function, cognitive 
impairment and dementia. In particular, vitamins B1, B3, B6, B9 and B12 are essential for neuronal 
function and deficiencies have been linked to depression. We discuss the causes of depression and the 
neurochemical pathways in depression. In particular, we provide evidence that vitamin B contributes to 
the complexity of depressive symptoms.  
 





 Unipolar major depression is the fourth most common disease suffered on a global scale [1] and  
in the next 20 years will become second only to heart disease as the leading cause of death and disability 
[2]. Patients suffering from unipolar depression experience an array of symptoms, such as an inability to 
function efficiently at work and home, feeling overwhelmed, miserable or worthless, experiencing a lack of 
confidence. Likewise, patients may experience physical manifestations like sleeplessness, fatigue, 
headache and muscle pain [3]. If left untreated, this disease can lead to functional impairment in both the 
short and long term. Depression is more prevalent amongst children and younger adults [4], with the 
greatest rate of suicide in Australia (7 per day) occurring in people aged 15-45 years [3]. However, on a 
worldwide scale, the World Health Organization reports that suicide amongst the elderly add considerably 
to the number of suicides, with a threefold rise in suicide rates in people over 75,  as compared to those 
aged 15–24 years [5]. Depression in young people can limit employment and education opportunities, as 
 well as lead to drug and alcohol dependence. Aggression, violence and other antisocial behaviors are 
more likely to occur in people suffering depression and this can significantly increase the burden placed 
on their families, friends and on society in general [4]. The economic load is considerable, with 
depression and anxiety comprising somewhere between a third and one half of the global cost of mental 
illness, with was estimated cost of $2.5 trillion in 2010, which is anticipated to increase to over $6 trillion 
by 2030 [6].  
  
1.1 Causes of Depression  
 
1.1.1. Genetics: Whilst a particular gene has not been identified that may predispose someone to 
depression, studies in twins have shown that the risk of developing familial clinical depression is as great 
as 50% [7]. Other studies have shown that epigenetic changes associated with hypermethylation of 
BDNF (Brain Derived Neutrophic Factor, encoded by the BDNF gene) and TrkB (Tropomyosin Receptor 
Kinase B, encoded by the NTRK 2 gene) are associated with higher incidence of suicide as a 
consequence of depression [8]. Likewise, the gene which codes for the serotonin transporter (5-HTT) and 
selective serotonin reuptake inhibitor drugs (SSRI’s) have proven to be effective in treating depression. 
Even though it is not clear whether polymorphisms within the 5-HTT gene are directly responsible for 
depression, in some individuals this may regulate the stress response of the the serotonergic system [9] 
 
1.1.2. Illness, Ageing brain:  Pre-existing long term illness or chronic pain and discomfort, coupled with 
a reduced physical capacity and the physical effects of an illness, can contribute to depression [10]. 
Management of chronic disease can therefore become more difficult when complicated by depression. 
Recognizing depression early in these patients may facilitate better management of the disease, thereby 
leading to improved outcomes in health and quality of life [11]. Numerous studies have shown that 
depression will often be preceded by some incident of significant life stress or coincide with related 
episodic stress. Animal studies have shown at a biochemical level that exposure to stressors can trigger 
hyperactivity of the central nervous system and corticotrophin-releasing factor neurons. The firing of these 
neurons leads to the discharge of corticotrophin, which regulates the endocrine, immune, autonomic and 
behavioral stress responses [12, 13] 
 A disruption of the neuronal circuits linking basal ganglia and frontal regions of the brain can be a 
contributing factor towards depression in the elderly. This disruption is often caused by alterations in 
blood pressure and sometimes undetected mini-strokes [14]. The ageing brain is more prone to 
inflammation, immune recruitment and metabolic syndrome, all of which can contribute to neurological 
disorders such as anxiety and depression [15]. In fact, during ageing, neuropeptides such as brain 
derived neurotrophic factors and somatostatin can lose up to 50% of their expression, as compared to 
control subjects [16]. In addition, social isolation and loneliness present other aggravating factors which 
contribute to depression in the elderly.  
  
2. NEUROCHEMICAL PATHWAYS AND DEPRESSION 
  
 B vitamins play an important role in the neurochemical pathways linked to depression; the 
glutamate and GABA neurotransmittory systems, as well as the serotonergic, noradrenergic, 
dopaminergic and cholinergic systems. Neurotransmitters, can contribute to depression if they fail to 
function normally. In fact, reduction in monoamine function plays a key role in depression.  In addition, 
reduction or interruption in serotonin transmission is a likely cause for all types of depression. More 
specifically, in melancholic or psychotic depression, other neurochemical pathways, such as 
dopaminergic and pathways for noradrenaline, are more likely to be functioning abnormally (Fig. 1) [14] 
[17]. The inhibition of serotonin (or 5-hydroxytryptamine; 5-HT) and norepinephrine transporters (in order 
to increase monoamine transmission) is achieved with selective 5-HT reuptake inhibitors and 5-HT 
norepinephrine reuptake inhibitors. Therefore, targeting monoamine receptors and additional transporters 
with multimodal drugs and triple re-uptake inhibitors is the foremost treatment option for depression [18] 
 
3. STRESS, MITOCHONDRIAL DYSFUNCTION AND DEPRESSION  
 
 Chronic stress has been widely recognized as a contributing factor to the onset of major 
depressive disorders [19-21]. The hypothalamic pituitary adrenal axis (or HPA axis) is triggered during 
periods of stress, resulting in increased levels of cortisol. It is thought that an imbalance between the way 
cortisol interacts with mineralocorticoid receptors (NR3C2) and glucocorticoid receptors (NR3C1) 
produces an inappropriate stress response, leading to depression [22]. The HPA axis can be initiated by 
various triggers. Monoamine neurotransmitters, such as serotonin and noradrenaline, are two such 
molecules which can trigger overproduction of HPA [22]. Serotonin and noradrenaline are synthesized by 
a process called one carbon metabolism, which uses co-enzymes derived from the vitamins folic acid, B6, 
B12 and B2 [23] .  
 Certain cytokines involved in immune reactions are also responsible for triggering HPA axis 
activity. Indeed, IL-1, IL-6, IL-10 and TNF-alpha exist in a bi-directional feedback loop which increase 
cortisol levels. However, if cortisol levels become too high inflammatory, reactions are suppressed as a 
protective mechanism. Furthermore, chronic stress and increased cortisol can lead to oxidative damage 
to mitochondrial function. Mitochondria provides a pivotal role in neurotransmitter signaling in brain 
synapses and damage sustained by oxidation can affect energy production, protein synthesis, lipid 
mediation, buffering of intracellular calcium and regulation of apoptotic pathways. Vitamin B12 and folic 
acid are known to protect against oxidative cell damage [22, 24]. 
 
4. INFLAMMATION AND DEPRESSION 
 
  The immune system consists of an intricate assembly of cells which function in a regulated 
manner in order to maintain health and well-being. Innate immunity begins immediately after, or within 
hours of, antigen stimuli. This involves mast cells, basophils, macrophages, dendritic cells, natural killer 
(NK)-cells, eosinophil’s and neutrophils. As a result of their activation, toxic metabolites are secreted, as 
are cytokines, chemokine’s and growth factors [25]. The adaptive immune response soon follows, 
involving antigen specific interactions by CD4+ and CD8+ T cells, NK-T cells and B cells. Over activation 
of peripheral immune system leads to increased activation of neurotoxic metabolites resulting from the 
tryptophan cascade, increased activation of microglial cells caused by circulating cytokines and alteration 
of brain function by peripheral stimulation of vagal nerve via afferent pathways [26]. As a consequence, 
this leads to modifications in the function and production of neurotransmitters, in particular serotonin, 
dopamine and glutamate. This can cause an inhibition of neurogenesis and neuroplasticity, which 
appears to have an active role in the pathogenesis of depression [27, 28].  
 
5. VAGAL STIMULATION AND THE BRAIN GUT AXIS IN DEPRESSION 
 Understanding how the immune system affects the brain has gained much attention in recent 
years, as inflammatory markers and antibodies are unable to penetrate through the blood brain barrier. In 
fact, the vagus nerve, which connects the brain to the abdomen, may be the key to this puzzle. 
Inflammatory responses in the gut are thought to send signals to the brain via the vagus nerve, which in 
turn stimulates the production of inflammatory mediators, acetylcholine and cytokines (such as, IL-6). This 
leads to an increase in metabolism and a decrease in brain serotonin levels which, through interaction 
with immune cells, attenuates inflammation. Toxic chemicals, such as nitric oxide, quinolinic acid and 
kynurenic acid, can also be stimulated for release by vagal signaling. These chemicals cause decreased 
function of nerve cells [29, 30]. In fact, the gut microbiome and intestinal permeability has mounting 
evidence linking it to brain development, function and behavior, through the immune, endocrine and 
neural pathways [31]. Certain probiotic treatments that are capable of controlling the brain-gut microbiota 
axis, termed psychobiotics, have been shown to deliver health benefits to patients experiencing 
psychiatric illness. It is thought that such benefits may be due to their anti-inflammatory action [32]. The 
term ‘psychobiotics’ has recently been conceived to encompass the sub-types of probiotics that may be 




6. VITAMIN B COMPLEX  
 
 Vitamin B complex plays an important role in the functioning of the methylation cycle involved in 
monoamine oxidase production, the synthesis of DNA, RNA, protein and phospholipid’s, and in cell 
 repair. The methylation cycle ensures proper immune function and inflammatory balance, maintains DNA, 
provides energy, and balances mood behaviors. Lowered methylation function is associated with a range 
of chronic conditions, including numerous neurological conditions, such as autism, schizophrenia, 
Alzheimer’s disease, psychiatric disorders, mood behaviors and depression [33].  
 
6.1. VITAMIN B AS CO-FACTORS  
 
 Vitamin B complex act as co-enzymes in enzymatic reactions. As a group they participate in the 
metabolism of carbohydrate, protein, lipids, vitamins, minerals and drugs, whilst taking part in a number of 
other cellular metabolic functions, including DNA synthesis (Table 1). 
 
6.1.1. Vitamin B1 (Thiamine): Thiamine is part of co-enzyme thiamine pyrophosphate, which plays a 
critical role in normal carbohydrate metabolism whereby it participates in both the decarboxylation of 
pyruvic and α-ketoglutarate acids and in the utilization of pentose in the hexose monophosphate shunt. 
Thiamine pyrophosphate also aids the conversion of pyruvate to acetyl CoA in the pyruvate 
dehydrogenase complex and also plays a part in the α-ketoglutarate-dehydrogenase complex in the TCA 
(Krebs) cycle, thereby converting a 5 carbon compound into a 4 carbon compound. Deficiency of thiamine 
in the diet can result in pyruvate not being converted to acetyl CoA. This in turn causes a rise in pyruvate 
and lactate levels in the blood. In animal tissue within the inner mitochondrial membrane, branched-chain 
α-ketoacid dehydrogenase complex uses thiamine pyrophosphate in an irreversible step in the catabolism 
of branched-chain amino acids which function in the Krebs cycle [34-38]. 
 
6.1.2. Vitamin B2 (Riboflavin): The two active forms of Riboflavin, Flavin mononucleotide (FMN) and 
Flavin adenine dinucleotide (FAD), function as cofactors for a number of important metabolic reactions. 
FAD occurs in two different redox states which it moves between by donating or accepting electrons. FAD 
is reduced to FAD-H2 to carry high energy electrons used for phosphorylation. FAD forms part of the 
complex II of the electron transport chain and is essential in the conversion of pyridoxal (Vitamin B6) to 
pyridoxic acid by pyridoxine 5’ phosphate oxidase and the conversion of retinol to retinoic acid via retinal 
dehydrogenase. FAD is also necessary for oxidating pyruvate, a-ketoglutarate and branched chain amino 
acids and reducing the oxidized form of glutathione to glutathione reductase in complex II of the electron 
transport chain. Fatty acyl Co-a dehydrogenase requires FAD in fatty acid oxidation and FADH2 
synthesizes an active form of folate (5- mehtyltetrahydrofolate) from 5,10-methylenetetrahydrofolate.  
FMN is an important component in the primary coenzyme form of Vitamin B6 and is required to convert 
tryptophan to niacin (Vitamin B3) in complex I of the electron transport chain. FMN reduces the oxidized 
form of glutathione to glutathione reductase in complex II of the electron transport chain [34, 39-43]. 
 
 6.1.3. Vitamin B3 (Niacin): Niacin and nicotinamide are both precursors of the coenzymes nicotinamide 
adenine dinucleotide (NAD) and ncotinamide adenine dinucleotide phosphate (NADPH). The enzyme 
NAD+ kinase phosphorylates NAD to NADPH, both act as coenzymes for many dehydrogenases which 
participate in hydrogen transfer processes. NAD is likewise a significant contributor to the catabolism of 
fat, carbohydrate, protein and alcohol, whereas NADPH mostly occurs in anabolistic reactions such as 
fatty acid and cholesterol synthesis. NAD is also required for cell signalling and DNA repair [34]. 
 
6.1.4. Vitamin B5 (Pantothenic Acid): Pantothenic acid, also called pantothenate or vitamin B5, 
contributes to the synthesis of fatty acids, cholesterol and acetylcholine and is required for the formation 
of acyl carrier protein, which is required for fatty acid synthesis. In energy metabolism, it assists pyruvate 
to enter the TCA cycle as acetyl-Co-A and the transformation of ketoglutarate to succinyl-CoA. CoA 
participates in acylation, which is important in signal transduction and acetylation, which is vital for 
enzyme activation and deactivation [34, 39, 44, 45]. 
  
6.1.5. Vitamin B6 (Pyridoxine): Also known as: pyridoxine (PN), pyridoxine-5’-phosphate (PNP), 
pyridoxal (PL), pyridoxal 5-phosphate (PLP), pyridoxamine (PM), pyridoxamine 5-phosphate (PMP) and 
4-pyridoxic acid (PA). Vitamin B6 is essential for amino acid metabolism, Glucose metabolism, Lipid 
metabolism, Hemoglobin synthesis and function and gene expression.  
Amino acid metabolism: PLP acts as a cofactor in the synthesis of neurotransmitters serotonin, 
dopamine, epinephrine, norepinephrine and GABA. It also synthesizes histamine. PLP, along with 
transaminases, break down amino acids and help move amine groups. The neuromodulator, serine, 
relies on PLP for synthesis and selenium relies on PLP for conversion into the primary dietary form 
selenomethionine and for the conversion of selenium into selenoproteins. PLP also aids the conversion of 
tryptophan to niacin. 
Glucose/lipid metabolism: Within glucose metabolism, PLP aids glucogen phosphorylase in the process 
of glucogenolyis, whilst in lipid metabolism, PLP facilitates the synthesis and the breakdown of 
sphingolipids such as ceramide [34, 46-52]. 
 
 
6.1.6. Vitamin B7 (Biotin): Biotin is a cofactor in several carboxylase enzymes, including acetyl-CoA 
carboxylase alpha, acetyl-CoA carboxylase beta, methylcrotonyl-CoA carboxylase, propionlyl-CoA 
carboxylase and pyruvate carboxylase. Biotin is important in the synthesis of fatty acids, in the catabolism 
of branched-chain amino acids and gluconeogenesis [34, 53-56]. 
 
6.1.7. Vitamin B9 (Folate): Folate in the form of tetrahydrofolate (THF) and other folate derivatives are 
important in a series of single carbon transfer reactions. It is important in methylation, along with B12 and 
B6, for recycling homocysteine into methionine and for the synthesis of DNA and the process of cell 
 division. Folate in the form of 5-MTHF helps to regulate the neurotransmission of monoamines and 
assists in DNA methylation and NO2 synthesis [23, 34, 42, 46, 51, 57-59].  
 
6.1.8. Vitamin B12 (Cobalamin): Vitamin B12 consist of reactive C-Co bonds which participate in 
Isomerase and methyltransferase reactions. MUT or methylmalonyl Co-enzyme-A mutase is an 
isomerase reaction in fatty acid oxidation which converts L-methylmalonyl Co-A to Succinyl Co-A before it 
enters the citric acid cycle, where it helps to extract energy from proteins and fats. MTR or 
Methyltransferase uses B12 as a cofactor to transfer a methyl group from 5-MTHFR to homocysteine, in 
order to generate THF and methionine used in the methylation cycle. If Vitamin B 12 is deficient, it causes 
an increase in homocysteine levels and folate is trapped in the cycle as 5-methyl-tetrahydrofolate instead 
of the active form, tetrahydrofolate. This can interfere with DNA production and reduce the body’s ability 
to produce rapid turnover cells, such as red blood cells, which can lead to megablastic or pernicious 
anaemia.  Here Vitamin B12 is needed to re-stablish MTR, or fresh folate is needed in the diet [13, 23, 34, 
46, 51, 60-63]. 
 
6.2. VITAMIN B AND THE METHYLATION CYCLE  
 
 Methylation is the mechanism by which the body deals with stress, toxins and infections. The 
methylation pathway deals with the balancing of neurotransmitters, the detoxification processes in the 
body, as well as controlling inflammation. Methylation reactions are involved in almost every chemical 
reaction undertaken within the body. The result of ineffective methylation reactions within the body are 
widespread and can result in many health conditions and diseases, including neurological disorders such 
as anxiety, depression, bipolar disorder, Alzheimer’s disease, fibromyalgia, neural tube defects, 
schizophrenia and sleep disorders [64]. 
 The enzyme methionine synthetase, catalyses the methylation of homocysteine to methionine [57]. 
The failure of this reaction to take place effectively leads to an increase levels of homocysteine in the 
blood, which can cause metabolic impairment. Several neurodegenerative disorders, including 
Parkinson’s, Alzheimer’s disease and depression, are characterized by increased homocysteine levels 
[57]. The toxic effect to vascular endothelial and neuronal cells caused by homocysteine elevation is well 
documented [65-67]. In order for levels of homocysteine to remain low in the central nervous system, an 
adequate amount of folate is required in the diet, as folate is essential in the methylation of homocysteine 
to methionine and in the synthesis of S-adenosyl-methionine, which is required for methylation of DNA, 
proteins and lipids. Low folate levels, especially in pregnancy, can cause neural tube defects, spina bifida, 
anencephaly, congenital malformations and birth defects in newborns [68]. Homocysteine, which is solely 
a product of the methylation cycle, acts as a sensitive marker of vitamin B12 and folate deficiency [57]. 
Numerous studies have linked low folate level to depression, in fact approximately one-third of depressed 
 patients are folate deficient [69], whilst folate supplementation reduces depressive and somatic symptoms 
in depressed patients [70]. 
 
7. THE EFFECTS OF VITAMIN B COMPLEX IN DEPRESSION 
 
 Vitamins play a major role in health and their deficiency is linked to symptoms of psychiatric 
disorders. Vitamin deficiencies could influence memory function, cognitive impairment and dementia. In 
particular, vitamin B1, B3, B6, B9 and B12 are essential for neuronal function and deficiencies have been 
linked to depression (Table 2). In fact, low intake of B vitamins is associated with poor adolescent mental 
health and behavior [71]. 
 
 7.1. VITAMIN B1 (THIAMINE)  
  
 Thiamine is found most abundantly in yeasts (brewers and bakers) and liver. The most important 
source in the diet, however, comes from cereal grain [72]. Thiamine is vital for the metabolism of 
carbohydrates and nerve function. Deficiency can lead to Beriberi, a disease which mainly affects the 
central nervous system, and Wernicke’s encephalopathy, a disease which is mostly associated with 
chronic alcoholism [35] (Table 3) 
  
Thiamine can be damaged by pH >6, heat, oxidation and ionizing radiation.  Thiamine is bound as serum 
proteins, mainly albumin, and it is absorbed in low concentrations by passive transport in upper small 
intestine and in high concentrations by active transport, mostly in jejunum and ileum. During metabolism 
of thiamine, 80% is phosphorylated and most is bound to proteins. Excretion occurs in the urine, as 
thiamine and acid metabolites (2-methyl-4-amino-5-pyrimidine carboxylic acid, 4-methyl-thiazole-5-acetic 
acid, and thiamine acetic acid) (Table 3) [73]. Numerous studies have highlighted the importance of 
adequate thiamine intake in the diet. It was reported over 35 years ago that low thiamin levels were 
common in newly admitted psychiatric patients. In particular, patients with depression and schizophrenia 
showed signs of clinical malnutrition and had low levels of thiamine. In 118 geriatric patients, an 
association with thiamine deficiency and depression was evident [74]. Likewise, in 1,587 older Chinese 
adults, poor thiamine nutritional status (low thiamine levels) was linked to depression [38]. Experimentally 
induced thiamine deficiency in dogs resulted in neurologic syndrome, or sudden unexpected death. In 
particular, symptoms included anorexia, paraparesis, convulsions, muscular weakness and depression 
[37]. Recently, the importance of adequate thiamin levels in the first year of life was demonstrated in 
infants with thiamin deficiency, leading to severe syntactic difficulties at age 5 or 9 due to a lack of brain 
development supporting syntactic abilities [75]. In addition, episodic memory dysfunction can occur sub-
acutely in patients as a result of thiamine deficiency [76], and a strong relationship between thiamine 
 deficiency and peripheral neuropathy exists in people with excessive consumption of alcoholic beverages 
[77]. 
 Thiamine supplementation for 6 weeks in 80 randomly selected elderly Irish women who were 
borderline thiamine deficient, resulted in decreased fatigue, improved sleep patterns and improved 
depression symptoms [78]. Likewise, in geriatric depressed patients, supplementation of thiamine, 
riboflavin and pyridoxine improved depression and cognitive function scores, compared to a placebo 
group [47]. Interestingly, a 50 year old male admitted to a psychiatric clinic in the Netherlands with 
symptoms of depression and a range of neurological disturbances, experienced partial remission of 
symptoms following thiamine supplementation [79]. In animal models with postpartum depression, the 
combination of zinc, magnesium and thiamine improved depressive symptoms and anxiety like behaviors 
[80]. Hence, it is clear that thiamine deficiency is involved in depression and its supplementation improves 
depressive symptoms. 
 
7.2. VITAMIN B2 (RIBOFLAVIN)  
 
 Riboflavin plays a vital role in the intermediary metabolism of carbohydrates, amino acids and 
lipids. Due to its ability to play a role in both one and two electron transfer processes, deficiency of this 
vitamin manifests first within tissues of rapid cellular turnover such as skin and epithelium, causing 
inflammation of membranes of mouth skin eyes and gastrointestinal tract  [72] (Table 3). Riboflavin is 
widely distributed in foods and is sensitive to high temperatures and light [81]. Non-covalently bonded 
riboflavin includes FMN (Flavin mononucleotide), FAD (Flavin adenine dinucleotide) and free riboflavin, 
which is well absorbed within tissues. Riboflavin is transported freely in the plasma and bound to plasma 
proteins, including immunoglobulin IgA, IgG and IgM [72]. Absorption takes place via a Na+ dependent 
carrier mediated process and receptor-mediated endocytosis across the placental barrier [40]. Following 
absorption, riboflavin is converted to its co-enzyme forms FMN and FAD. Excretion is via the urine mainly 
as free Riboflavin. It is also secreted into milk in amounts dependent on the riboflavin intake of the mother 
[72].  
 A meta analysis systemic review of the micronutrient intake of older adults demonstrated that a 
deficiency of riboflavin and thiamin was linked with poor cognitive outcomes [82]. Interestingly, a link 
between riboflavin and vitamin D metabolism, an insufficient riboflavin availability and an imbalance of 
FAD and FMN, results in a distinct alteration in structure within the skeletal and central nervous systems 
[83]. 
 
7.3. VITAMIN B3 (NIACIN)  
 
 Brewers yeast is the most significant food source of niacin and it is found in a wide range of 
foods, including meat and wholegrains. Within food sources, niacin is predominantly bound to proteins in 
the forms of nicotinic acid, nicotinamide, nicotinamide adenine-dinucleotide (NAD) and nicotinamide-
 adenine dinucleotide phosphate (NADP). NAD and NADP are pyridine nucleotides that act as vital 
cofactors for enzymes in many areas of metabolism (Table 1). Niacin is absorbed in the form of 
nicotinamide and nicotinic acid in the stomach and small intestine via Na+ dependent carrier mediated 
facilitated diffusion, stored predominantly in the liver as NAD+, NADH and NADPH and excreted in the 
urine as N1-methyl-nicotinamide and its 2-pyridone derivative (N1-methyl-2-pyridone-5-carboxamide) 
[72]. (See table 1) 
 In the 1950s, niacin (or nicotinic acid) was implicated in the treatment of schizophrenia manic 
depression, benign depression and tension anxiety conditions. Indeed, numerous studies showed 
improved depressive and anxiety reactions following niacin supplementation [45]. In recent years, other 
than niacin effectively treating delusion [84], limited studies have determined the link between niacin and 
depression. However, in 30 patients with recurrent unipolar depressive disorder, treatment with aqueous 
niacin skin flushing significantly improved depression, anxiety and somatic symptoms [85]. Further studies 




 A substance is classed as cholinergic if it is capable of producing, altering or releasing 
acetylcholine. Similarly, a receptor or synapse is cholinergic if it uses acetylcholine as a transmitter (Fig. 
1) [86]. Choline is classed with B vitamins based on its chemical structure, but is not necessarily defined 
as such [87]. It is important in cell membrane structure and plasma lipoproteins, as it aids in the synthesis 
of the phospholipid components. In addition, it plays a role in the cell signaling function of membranes.  In 
tissues, choline facilitates movement of fats into cells and prevents fat deposits in the liver. In fact, rats 
fed a choline-deficient diet develop fatty liver and humans develop hepatosteatosis which can be 
corrected with choline supplementation [88]. Furthermore, choline is the primary component of 
acetylcholine, a neurotransmitter used primarily by the parasympathetic nervous system and at 
neuromuscular junctions and preganglionic neurons. Cytosolic choline levels in the brain, whether 
deficient or in excess, have been linked to depression and anxiety. Proton magnetic resonance spectra, 
taken from 17 depressed and 28 healthy adolescents, indicated that choline creatine ratios and choline/N-
acetyl aspartate ratios were significantly higher in the depressed group [89]. However, in a large 
population-based study, choline concentrations were negatively associated with anxiety symptoms, but 
not depression [90]. Further, rats fed a choline supplemented perinatal diet, out-performed control rats in 
in an open-water learning maze and forced swim test [91]. Hence, choline supplementation during 
development may prevent stress and depression. (Table 3) 
 
 7.5. VITAMIN B5 (PANTOTHENIC ACID) 
 
 Pantothenic acid is widely distributed in foods with the richest source coming from meat (liver, 
heart), avocado, broccoli and some yeasts. At low concentrations it is transported by facilitated transport 
 and at high concentrations by passive diffusion. Pantothenic acid of dietary origin has the ability to 
synthesize coenzyme A (CoA) in most tissues of the body. CoA is an important co-factor for many 
enzymes involved in intermediary metabolism. Excretion of pantothenic acid occurs mostly in the urine, as 
free pantothenic acid and some 4’-phosphopanthenate, however 15% of pantothenic acid is also oxidized 
and excreted through the lungs as CO2. Several studies to date have reported that amides derived from 
pantothenic acid possess an antibiotic quality within the body, which may prove to be a novel antibiotic 
solution to appropriately relevant gram positive bacteria [92] or malarial agents [93]. Higher levels of 
nutrient intake, including pantothenic acid, results in better mental health scores, as based on the global 
assessment of functioning scores and the Hamilton depression rating scale [39]. Further studies are 
required to determine whether pantothenic acid plays a role in mental health disorders, including 
depression. (Table 3) 
 
 7.6. VITAMIN B6 (PYRIDOXINE)  
 
 Vitamin B6 constitutes three interrelated isoforms, pyridoxine, pyridoxal, and pyridoxamine. All 
three pyrimidine derivatives are naturally occurring and are endogenously converted to pyridoxine- 
pyridoxal- pyridoxamine-5’-phosphate [94]. Vitamin B6 is present in a wide variety of foods, mostly in 
meats, whole grains, vegetables and nuts. Bioavailability of B6 in food is within a range of around 70-80% 
and absorption of B6 takes place via passive diffusion in the jejunum and ileum [95].  
 Vitamin B6 (pyridoxine, pyridoxal and pyridoxamine) is involved in the regulation of mental 
function and mood. It impacts on neurotransmitters, which control depression, pain perception and 
anxiety. Its deficiency results in high homocysteine levels and has been linked to seizures, migraines and 
depression. Indeed, in 140 individuals studied, a clear correlation was noted between depression and low 
plasma pyridoxal levels [96]. Supplementation of vitamin B6 reduces homocysteine blood levels and 
improves mood, psychotic symptoms in schizophrenia, fatigue, cognitive function and depression [50]. In 
addition, reduced depressive symptoms were evident following 4 weeks of pyridoxine administration in 
schizophrenic patients [97]. Likewise, combined pyridoxine and magnesium supplementation for 4 weeks 
reduced anxiety-related premenstrual symptoms and depression, and a combination of pyridoxine and 
estradiol improves major depression in women [48]. Interestingly, pyridoxine intoxication in rats results in 
severe sensory neuropathy, as substantiated by behavioral deficits [98] (Table 3) 
 Glutamate in mammals is one of the major excitatory neurotransmitters, which exists in extremely 
high levels in brain tissue. These levels can be toxic and tight regulation of this system is needed in order 
to balance the excitatory potential, whilst limiting exotoxic damage. The physiology required to maintain 
the balance of this system is complex and multifaceted [99]. In addition, glutamate takes part in other 
functions in the body, including synthesis of proteins and peptides, energy production and ammonia 
detoxification. 
 
 7.6.1. Vitamin B6 and glutamernergic system: Glutamate is synthesized in the brain by 2 processes; (i) 
glucose is used as a precursor, whereby it enters the Krebs cycle and is transaminated by α-oxoglutarate 
transaminase to form glutamate, and, (ii) reuptake of glutamate by glial cells, where it is converted to 
glutamine and transported to the neuronal terminal, where it is converted back to glutamate, packaged 
into synaptic vesicles and stored for reuse at a later time [100]. Glutamate serves as a metabolic 
precursor to gamma amino butyric acid (GABA), which is an inhibitory neurotransmitter found in high 
concentrations in brain tissue and the spinal cord, although absent in peripheral nerves [100]. Brain 
seizure disorders, such as epilepsy, can be facilitated by a reduction of GABA levels, which cause a 
reduction of neuronal inhibition leading to seizures  [100, 101]. Bipolar disorder and major depression are 
both linked to dysfunction of the glutamate system, which may be due to the degradation of quinolinic 
acid, a metabolite of tryptophan [102]. 
 In a cohort of patients suffering from depression, significantly lower concentrations of GABA in 
the lower occipital cortex were noted as compared to controls, whilst mean glutamate levels were 
considerably increased [103]. In addition, drugs that modulate glutamatergenic synapses produce 
antidepressant like activities and interfere with glutamate metabolism receptors, which are often linked to 
depression and suicidality [104]. A correlation between high glutamate levels and anxiety in humans has 
been reported [105]. Furthermore, vitamin B6 is integral in GABA synthesis and vitamin B6 
supplementation is used to treat early onset of epilepsy in children with inborn errors of vitamin B6 
metabolism [52]. Recently, it was demonstrated that food poisoning from Ginkgo biloba seeds can cause 
epilepsy, since Ginkgo biloba decreases vitamin B6 levels, which decreases GABA concentrations in the 
brain [49].   
  
7.6.2. Vitamin B6 and serotonergic system:  Serotonin is a signalling molecule found in blood vessels, 
the gut and other parts of the body. It is produced mainly in the brain in the raphe nuclei, which has 
connections throughout the brain and spinal chord. Serotonin is a modulatory chemical, which can have 
an effect on a number of conditions, including mood, anxiety, circadian rhythms, bowel problems, 
migraines, memory, nausea, and vasoconstriction/dilation. Serotonin (5-HT) is formed from L-tryptophan. 
When serotonin is released into the synaptic cleft it is taken up by serotonin receptors on the postsynaptic 
neuron. Following the binding of serotonin to receptors on the postsynaptic neuron, where it performs its 
function of signal transduction, it is then released again into the synaptic cleft. Serotonin can remain in the 
synaptic cleft or it can be taken up into the presynaptic neuron by serotonin transporters, where it is 
recycled and used again. Both serotonin transporters and monoamine oxidase are targets for anti-
depressant drugs [106]. Dietary intake of serotonin is unable to be accessed by the body, due to the 
blood brain barrier. Tryptophan, however, can cross the blood brain barrier and diets poor in tryptophan 
or vitamin B6, which act as co-factors to facilitate the conversion of L-tryptophan to serotonin, may induce 
depression [106-108]. 
  Furthermore, low monoamine levels, particularly serotonin, can lead to symptoms of depression. 
This theory was first postulated in the 1960’s [109] and the subsequent studies have developed drugs to 
raise the synaptic serotonin levels without affecting other monoamines, by working on serotonin receptors 
[110]. Selective serotonin reuptake inhibitors are now amongst the most commonly prescribed drugs in 
the treatment of depression. Other studies have demonstrated that a low number of receptors relating to 
an underlying abnormality in the serotonin system could be a cause for low serotonin serum levels; 
increasing serotonin levels aids in increasing serotonin receptors, thereby increasing serotonin 
transmission [109]. Diets rich in vitamin B6 and tryptophan help boost serotonergic neurotransmission in 
depression observed in various neurodegenerative diseases. In fact, vitamin B6 deficient rats are highly 
susceptible to seizure disorders [111]. In addition, 140 individuals with symptoms of depression were 
shown to have significantly low levels of plasma pyridoxal phosphate, the phosphate derivative of vitamin 
B6 [96]. Furthermore, patients suffering from depression have elevated plasma homocysteine levels, 
which correlate with low vitamin B6 and folate levels [112]. 
 
7.7. VITAMIN B7 (BIOTIN) 
 
 Biotin is found in liver, egg yolks, soy beans, fish, whole grains and is important for 
gluconeogenesis, fatty acid synthesis and amino acid catabolism (Table 3). Avidin, present in egg whites, 
binds to biotin tightly [53] and prevents its absorption within the tissues. Biotin is synthesized by the 
normal micro flora of the large intestine and is partly absorbed by colonocytes. Over 30 years ago, it was 
noted in a patient with severe depression accompanied by delirium, that paresthesia and headache were 
improved following treatment with biotin [54]. Few studies are available which determine whether biotin 
plays a role in depression, although recently it was noted that inherited biotinidase deficiency in newborns 
leads to neurological abnormalities [113] (Table 3). 
 
 
7.8. VITAMIN B9 (FOLATE)  
 
 Vitamin B9 (folate, folic acid, vitamin M, vitamin Bc) is found widely in foods, but is particularly 
abundant in foods of plant origin. It is closely associated with vitamin B12 and vitamin B6 in maintaining 
normal metabolic processes. When taken in food, folates are in the form of polyglutamates. Folate 
reductase enzymatically converts polyglutamates into folate monoglutamates within the mucosa of the 
jejunum. This process is necessary before absorption can take place in the small intestine by Na+ -
coupled carrier mediated processes (Table 3).  
 Folate is required for the synthesis, repair and methylation of DNA and is important for a number 
of biological reactions. Low folate levels have been linked to depression, according to 11 different studies 
with a total of 15,315 participants [114]. Low plasma or serum folate has also been found in patients with 
 recurrent mood disorders being treated by lithium. Interestingly, in Hong Kong and Taiwan populations 
with rich folate diets, there is a low incidence of major depression. Patients who respond poorly to anti-
depressant medication are usually those with low folate levels; folic acid supplementation improves 
responses to medication, as reviewed in [115]. In 517 Japanese adults (21-67 years) folate 
supplementation showed an inverse and linear association with depressive symptoms in males, but not 
females [42]. Riboflavin, pyridoxine, cobalamin and omega-3 intake showed no correlation. However, 
folate intake had no effect on the risk of postpartum depression, although moderate consumption of 
riboflavin showed evidence of protection against postpartum depression [51]. In the Finnish male 
population, 2,682 participants were recruited and those with the lowest intake of folate had a higher risk of 
being depressed, compared to those with the highest folate intake [116]. A more recent Australian review 
and meta analyses on folate and B12 in depression suggests that increasing these two vitamins in the 
diet does not lessen the severity of depressive symptoms in the short term, but may assist in the ongoing 
management of depression in select populations [117]. However, in a Turkish cohort there was no 
difference in serum folate and B12 levels between depressive and non-depressive post-menopausal 
women and that supplementation of folic acid and B12 did not reduce depressive symptoms [118]. On the 
basis of this data, further studies are required to determine the effects of folic acid supplementation to 
improve treatment outcomes in depression. In fact, folic acid supplementation affects noradrenalin and 
serotonin receptors in the brain, suggesting its ability to have antidepressive effects. 
 
7.8.1. Folate and dopaminergic system: Folate is needed in the brain for the synthesis of dopamine. 
[70]. Dopamine, a catecholamine-classed neurotransmitter, is found in numerous areas of the midbrain, 
including the substania nigra, retrorubral and ventral mesencephalon. The dopaminergic pathway, 
extending from these regions, innervates the forebrain of mammals and other peripheral tissue (on which 
it performs an exocrine or paracrine function) [119]. Dopaminergic neurons are responsible for higher 
motor function and goal orientated behavior, including reward, motivation and working memory, as well as 
learning and prediction [120]. Motor diseases, such as Parkinson’s, and neuropsychological conditions, 
including obsessive compulsive behavior and schizophrenia, depression and drug addiction, are 
associated with the selective loss of dopamine neurons, or interruption to the dopaminergic system (Fig. 
1) [121-123]. Pharmacologically, decreasing dopamine levels in patients has been shown to result in an 
induction or deepening of depression symptoms [124]. Likewise, the firing capabilities of dopaminergic 
neurons in an animal model of depressed rats showed decreased neuron-bursting activity, hence lower 
dopamine release into the synapse compared to normal rats [123]. Interestingly, this area of research has 
led to deep brain stimulation in an attempt to increase dopamine levels, currently used in the treatment of 
Parkinson’s [123]. Recently, it was noted that an increase in cholinergic levels in mice resulted in 
depression, according to the tail suspension test and forced swim test, whilst increased dopamine levels 
led to mania-like behavior [125]. 
 
 7.9. VITAMIN B12 (COBALAMIN)  
 
 Vitamin B12 is a generic description for all compounds which contain a cobalt centered corrin 
nucleus. The action of B12 is interrelated with that of folate. The metabolically active form of B12 is 
cyanocobalamin, however other forms found naturally in biological systems include methylcobalamin, 
cob(I)alamin, 5’-deoxyadenosylcobalamin and hydroxycobalamin. B12 is stable to heat, soluble in water, 
but sensitive to light [126]. Vitamin B12 is synthesized by bacteria and stored within the tissue of animals 
and is therefore not present in plant sources, making the dietary intake of this vitamin a concern for 
people who follow a vegan diet [62]. Dietary B12 is bound to protein in food and released by hydrochloric 
acid and gastric proteases in the stomach. Once released from food-binding, proteins then bind to B12, 
transporting and protecting it from stomach acid and catabolism by intestinal bacteria. Intrinsic factor, 
secreted by parietal cells in the stomach, complexes with B12 and is absorbed in the small intestine. 
Following absorption, B12 moves into the circulation and is transferred into a cell via a plasma 
transporter, transcobalamin II. Once inside the cell, lysosomal activity degrades the transcobalamin II-B12 
complex and free B12 is released into the cytoplasm [127]. People who undergo bariatric surgery are at 
risk of vitamin B12 deficiency due to gastric resection [128, 129]. Likewise, people who follow vegan diets 
are at risk for B12 deficiency, owing to inadequate intake. Common clinical symptoms suffered due to 
B12 deficiency include fatigue and weakness, constipation, loss of appetite and weight loss, balance 
issues, depression and cognitive disturbances, peripheral tingling and soreness of the mouth and tongue 
[130] (Table 3). 
 Vitamin B12 (cobalamin) plays a major role in the normal functioning of the brain and the nervous 
system. It is involved in the synthesis and regulation of DNA and metabolism of amino acids and fatty 
acids. Vitamin B12 deficiency results in severe symptoms of depression, suicidal behaviors, cognitive 
decline, irritability, mania and psychosis, thus affecting the health and well-being of individuals. Indeed, 
vitamin B12 deficiency is found in up to one-third of depressed patients and higher vitamin B12 levels are 
associated with better treatment outcomes. In addition, low vitamin B12 increases the risk of cognitive 
decline, dementia and Alzheimer’s disease and is linked to a five-fold increase in the rate of brain 
atrophy. In fact, high B12 levels protects against brain atrophy associated with Alzheimer’s disease and 
cognitive decline [131]. Furthermore, in a Finnish group,  low B12 was associated with risk for 
melancholic depressive symptoms, but not with non-melancholic depressive symptoms [132]; low B12 
levels were also associated with bipolar depression [133]. This supports the hypothesis that low B12 is 
linked with diminished synthesis of serotonin and other monoamine neurotransmitters [132]. In a study of 
20 geriatric and 16 alcoholic patients with major depression, deficiency in B12 levels (and riboflavin and 
pyridoxine levels) were evident [134]. The recent Quebec longitudinal study on nutrition and aging,  
comprising 1,792 participants,  demonstrated that low B12 levels were associated with depression in men 
and low B6 levels were associated with depression in women [135]. However, in post-menopausal 
 women, at high risk of depression, there was no correlation between B12 (and folate) levels and 
depressive symptoms [118]. 
 Given that there is a link between B12 deficiency and depression, B12 supplementation should 
theoretically improve depressive symptoms. Indeed, in a study comprising 199 patients with depression 
on antidepressants, B12 injections significantly improved depressive symptoms [136]. Long term 
supplementation over 24 months of B12 improved cognitive function and depressive symptoms in a study 
in of 900 depressed adults aged 60-74 years [137]. Further studies are therefore warranted to ascertain 
the effects of B12 supplementation in depression. 
 
7.9.1. Cobalamin and noradrenergic system: The noradrenergic system participates in the synthesis,  
storage and release of noradrenaline (norepinephrine). Dysregulation of noradrenergic function,  most 
commonly associated with over activation of this system,  can lead to many symptoms of anxiety and 
depression (Fig. 1) [138]. Norepinephrine is a monoamine,  consisting of a single amine group and a 
benzene ring with 2 hydroxyl groups. It is released by the sympathetic nervous system and mediates the 
flight or fight response, preparing the body for “action’ by affecting cardiovascular function, 
bronchodilation, gastrointestinal motility and secretion, and glucose metabolism. Within the central 
nervous system,  norepinephrine is associated with sleep, memory, learning and emotion [139]. 
Noradrenaline is synthesized in the nerve axon and stored in synaptic vesicles in nerve terminals. It binds 
to receptors when needed. Noradrenaline that is not stored is degraded by monoamine oxidase [140]. 
Folate and vitamin B12 aid in the metabolism of monoamine neurotransmitters such as norepinephrine. 
Indeed, folate deficiency could cause impaired methylation and monoamine metabolism, leading to 






 Depression is a multicausal disorder, being a metabolic disorder, cardiovascular disorder, 
endocrinological disorder, stress disorder and nutritional disorder. Up to the present time,  vitamin B 
cannot replace medication,  especially in severe depressive symptomatology,  but could be used as an 
adjunct treatment. It is clear that vitamin B complex plays a role in depression, however further studies 




 Depression could manifest as an immunological disorder. Pro-inflammatory cytokines, IL-1-beta, 
IL-2 receptor, IL-6, IL-8, IL-10, TNF-alpha, IFN-alpha, and, C-reactive protein, haptoglobin, toll like 
 receptor 4, cyclooxygenase-2, prostaglandin-E2, lipid peroxidation levels and acid sphingomyelins have 
all been implicated in being involved in the neurobiological manifestation of depression [142]. In fact, anti-
TNF-alpha treatment decreased depressive symptoms and improved sleep continuity in resistant major 
depressive patients with baseline high inflammation [143]. Likewise, curcumin, a natural anti-
inflammatory,  improves major depressive disorder symptoms [144]. In an English longitudinal study of 
ageing, consisting of 3,397 participants, high c-reactive protein levels were associated with elevated 
depressive symptoms [145]. Interestingly, a meta-analysis of 18 studies, comprising 583 depressed 
patients with suicidality, 315 patients without suicidality and 845 control subjects,  demonstrated that high 
levels of IL-1-beta and IL-6 correlated with patients with suicidality,  as compared to patients without 
suicidality and control subjects. Hence, IL-1-beta and IL-6 may aid in the ability to distinguish between 
suicidal and non-suicidal patients [146]. The immune-cytokine network has powerful control over the 
brain, increasing its sensitivity to stress, anxiety and depression, hence it is imperative to further 
understand the role the immune system plays in depression. Moreover, the effects of vitamin B on 
immune cell functionality will aid in an understanding of the role vitamin B and immune cells play in 
depression. The development of an effective prescription of a rich vitamin B source for patients with 
depression may provide a valuable supplement to existing therapeutic strategies for patients with 
depression. 
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CoA = Coenzyme A 
FAD = Flavin adenine dinucleotide 
FMN = Flavin mononucleotide 
GABA = Gamma amino butyric acid 
IFN = Interferon 
IL = Interleukin 
NAD = Nicotinamide adenine-dinucleotide 
NADP = Nicotinamide-adenine dinucleotide phosphate 
TNF =  Tumor necrosis factor 





[1] Murray, C.J.; Lopez, A.D., Global mortality, disability, and the contribution of risk factors: Global 
 Burden of Disease Study. Lancet, 1997, 349, (9063), 1436-1442. 
[2] Whitecloudfoundation, White cloud foundation - Depression Facts. 
 (http://www.whitecloudfoundation.org/depression-facts). , 2014. 
[3] Beyondblue, Beyond Blue- Depression and Anxiety   
 (http://www.beyondblue.org.au/). , 2014. 
[4] Burns, J.; Birrell, E., Enhancing early engagement with mental health services by young people. 
 Psychology research and behavior management, 2014, 7, 303-312. 
[5] Oude Voshaar, R.C.; van der Veen, D.C.; Hunt, I.; Kapur, N., Suicide in late-life depression with 
 and without comorbid anxiety disorders. International journal of geriatric psychiatry, 2015. 
[6] Who press, G.S., The Global burden of disease: 2004 Update World Health Organization 2008. 
[7] Levinson, D.F., Major Depression and genetics 
 http://depressiongenetics.stanford.edu/mddandgenes.html, 2015. 
[8] Lockwood, L.E.; Su, S.; Youssef, N.A., The role of epigenetics in depression and suicide: A 
 platform for gene-environment interactions. Psychiatry research, 2015, 228, (3), 235-242. 
[9] Caspi, A.; Sugden, K.; Moffitt, T.E.; Taylor, A.; Craig, I.W.; Harrington, H.; McClay, J.; Mill, J.; 
 Martin, J.; Braithwaite, A.; Poulton, R., Influence of life stress on depression: moderation by a 
 polymorphism in the 5-HTT gene. Science, 2003, 301, (5631), 386-389. 
[10] Ritter, P.L.; Ory, M.G.; Laurent, D.D.; Lorig, K., Effects of chronic disease self-management 
 programs for participants with higher depression scores: secondary analyses of an on-line and a 
 small-group program. Translational behavioral medicine, 2014, 4, (4), 398-406. 
[11] Health Quality, O., Screening and management of depression for adults with chronic diseases: an 
 evidence-based analysis. Ontario health technology assessment series, 2013, 13, (8), 1-45. 
[12] Dabrowska, J.; Hazra, R.; Guo, J.D.; Dewitt, S.; Rainnie, D.G., Central CRF neurons are not 
 created equal: phenotypic differences in CRF-containing neurons of the rat paraventricular 
 hypothalamus and the bed nucleus of the stria terminalis. Front Neurosci, 2013, 7, 156. 
[13] Malouf, M.; Grimley, E.J.; Areosa, S.A., Folic acid with or without vitamin B12 for cognition and 
 dementia. The Cochrane database of systematic reviews, 2003, (4), CD004514. 
[14] Blackdoginstitute, Causes of Depression 
 http://www.blackdoginstitute.org.au/public/depression/causesofdepression/index.cfm, 2014. 
[15] Sibille, E., Molecular aging of the brain, neuroplasticity, and vulnerability to depression and other 
 brain-related disorders. Dialogues in clinical neuroscience, 2013, 15, (1), 53-65. 
[16] Erraji-Benchekroun, L.; Underwood, M.D.; Arango, V.; Galfalvy, H.; Pavlidis, P.; Smyrniotopoulos, 
 P.; Mann, J.J.; Sibille, E., Molecular aging in human prefrontal cortex is selective and continuous 
 throughout adult life. Biological psychiatry, 2005, 57, (5), 549-558. 
[17] Furmaga, H.; Shah, A.; Frazer, A., Serotonergic and noradrenergic pathways are required for the 
 anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in 
 rats. Biological psychiatry, 2011, 70, (10), 937-945. 
[18] Dale, E.; Bang-Andersen, B.; Sanchez, C., Emerging mechanisms and treatments for depression 
 beyond SSRIs and SNRIs. Biochemical pharmacology, 2015, 95, (2), 81-97. 
[19] Salleh, M.R., Life event, stress and illness. Malays J Med Sci, 2008, 15, (4), 9-18. 
[20] Schneiderman, N.; Ironson, G.; Siegel, S.D., Stress and health: psychological, behavioral, and 
 biological determinants. Annu Rev Clin Psychol, 2005, 1, 607-628. 
[21] Slavich, G.M.; Irwin, M.R., From stress to inflammation and major depressive disorder: a social 
 signal transduction theory of depression. Psychol Bull, 2014, 140, (3), 774-815. 
[22] Schatzberg, A.F.; Keller, J.; Tennakoon, L.; Lembke, A.; Williams, G.; Kraemer, F.B.; Sarginson, 
 J.E.; Lazzeroni, L.C.; Murphy, G.M., HPA axis genetic variation, cortisol and psychosis in major 
 depression. Mol Psychiatry, 2014, 19, (2), 220-227. 
[23] Selhub, J., Folate, vitamin B12 and vitamin B6 and one carbon metabolism. J Nutr Health Aging, 
 2002, 6, (1), 39-42. 
[24] Du, J.; Zhu, M.; Bao, H.; Li, B.; Dong, Y.; Xiao, C.; Zhang, G.Y.; Henter, I.; Rudorfer, M.; Vitiello, 
 B., The Role of Nutrients in Protecting Mitochondrial Function and Neurotransmitter Signaling: 
  Implications for the Treatment of Depression, PTSD, and Suicidal Behaviors. Critical reviews in 
 food science and nutrition, 2014, 0. 
[25] Anogeianaki, A.; Castellani, M.L.; Tripodi, D.; Toniato, E.; De Lutiis, M.A.; Conti, F.; Felaco, P.; 
 Fulcheri, M.; Theoharides, T.C.; Galzio, R.; Caraffa, A.; Antinolfi, P.; Cuccurullo, C.; Ciampoli, C.; 
 Felaco, M.; Cerulli, G.; Pandolfi, F.; Sabatino, G.; Neri, G.; Shaik-Dasthagirisaheb, Y.B., Vitamins 
 and mast cells. International journal of immunopathology and pharmacology, 2010, 23, (4), 991-
 996. 
[26] Pariante, C.M., Neuroscience, mental health and the immune system: overcoming the brain-
mind- body trichotomy. Epidemiology and psychiatric sciences, 2015, 1-5. 
[27] Bull, S.J.; Huezo-Diaz, P.; Binder, E.B.; Cubells, J.F.; Ranjith, G.; Maddock, C.; Miyazaki, C.; 
 Alexander, N.; Hotopf, M.; Cleare, A.J.; Norris, S.; Cassidy, E.; Aitchison, K.J.; Miller, A.H.; 
 Pariante, C.M., Functional polymorphisms in the interleukin-6 and serotonin transporter genes, 
 and depression and fatigue induced by interferon-alpha and ribavirin treatment. Mol Psychiatry, 
 2009, 14, (12), 1095-1104. 
[28] Eyre, H.; Baune, B.T., Neuroplastic changes in depression: a role for the immune system. 
 Psychoneuroendocrinology, 2012, 37, (9), 1397-1416. 
[29] Forsythe, P.; Bienenstock, J.; Kunze, W.A., Vagal pathways for microbiome-brain-gut axis 
 communication. Adv Exp Med Biol, 2014, 817, 115-133. 
[30] Khandaker, G.M.; Pearson, R.M.; Zammit, S.; Lewis, G.; Jones, P.B., Association of serum 
 interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult 
 life: a population-based longitudinal study. JAMA psychiatry, 2014, 71, (10), 1121-1128. 
[31] Kelly, J.R.; Kennedy, P.J.; Cryan, J.F.; Dinan, T.G.; Clarke, G.; Hyland, N.P., Breaking down the 
 barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front 
 Cell Neurosci, 2015, 9, 392. 
[32] Dinan, T.G.; Stanton, C.; Cryan, J.F., Psychobiotics: a novel class of psychotropic. Biological 
 psychiatry, 2013, 74, (10), 720-726. 
[33] Dauncey, M.J., Genomic and epigenomic insights into nutrition and brain disorders. Nutrients, 
 2013, 5, (3), 887-914. 
[34] Cox., D.L.N.M.M. Principles of Biochemistry  Freeman, 2013. 
[35] Abdou, E.; Hazell, A.S., Thiamine Deficiency: An Update of Pathophysiologic Mechanisms and 
 Future Therapeutic Considerations. Neurochemical research, 2014. 
[36] Carney, M.W.; Williams, D.G.; Sheffield, B.F., Thiamine and pyridoxine lack newly-admitted 
 psychiatric patients. The British journal of psychiatry : the journal of mental science, 1979, 135, 
 249-254. 
[37] Read, D.H.; Harrington, D.D., Experimentally induced thiamine deficiency in beagle dogs: clinical 
 observations. American journal of veterinary research, 1981, 42, (6), 984-991. 
[38] Zhang, G.; Ding, H.; Chen, H.; Ye, X.; Li, H.; Lin, X.; Ke, Z., Thiamine nutritional status and 
 depressive symptoms are inversely associated among older Chinese adults. The Journal of 
 nutrition, 2013, 143, (1), 53-58. 
[39] Davison, K.M.; Kaplan, B.J., Nutrient intakes are correlated with overall psychiatric functioning in 
 adults with mood disorders. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 
 2012, 57, (2), 85-92. 
[40] Foraker, A.B.; Khantwal, C.M.; Swaan, P.W., Current perspectives on the cellular uptake and 
 trafficking of riboflavin. Advanced drug delivery reviews, 2003, 55, (11), 1467-1483. 
[41] Massey, V., The chemical and biological versatility of riboflavin. Biochemical Society transactions, 
 2000, 28, (4), 283-296. 
[42] Murakami, K.; Mizoue, T.; Sasaki, S.; Ohta, M.; Sato, M.; Matsushita, Y.; Mishima, N., Dietary 
 intake of folate, other B vitamins, and omega-3 polyunsaturated fatty acids in relation to 
 depressive symptoms in Japanese adults. Nutrition, 2008, 24, (2), 140-147. 
[43] Powers, H.J., Riboflavin (vitamin B-2) and health. The American journal of clinical nutrition, 2003, 
 77, (6), 1352-1360. 
[44] Fu, L.; Doreswamy, V.; Prakash, R., The biochemical pathways of central nervous system neural 
 degeneration in niacin deficiency. Neural regeneration research, 2014, 9, (16), 1509-1513. 
[45] Thompson, L.J.; Proctor, R.C., Depressive and anxiety reactions treated with nicotinic acid and 
 phenobarbital. North Carolina medical journal, 1953, 14, (9), 420-426. 
 [46] Balk, E.M.; Raman, G.; Tatsioni, A.; Chung, M.; Lau, J.; Rosenberg, I.H., Vitamin B6, B12, and 
 folic acid supplementation and cognitive function: a systematic review of randomized trials. 
 Archives of internal medicine, 2007, 167, (1), 21-30. 
[47] Bell, I.R.; Edman, J.S.; Morrow, F.D.; Marby, D.W.; Perrone, G.; Kayne, H.L.; Greenwald, M.; 
 Cole, J.O., Brief communication. Vitamin B1, B2, and B6 augmentation of tricyclic antidepressant 
 treatment in geriatric depression with cognitive dysfunction. Journal of the American College of 
 Nutrition, 1992, 11, (2), 159-163. 
[48] Holsboen, F.; Benkert, O.; Meier, L.; Kreuz-Kersting, A., Combined estradiol and vitamin B6 
 treatment in women with major depression. The American journal of psychiatry, 1985, 142, (5), 
 658. 
[49] Kobayashi, D.; Yoshimura, T.; Johno, A.; Ishikawa, M.; Sasaki, K.; Wada, K., Decrease in 
 pyridoxal-5'-phosphate concentration and increase in pyridoxal concentration in rat plasma by 4'-
 O-methylpyridoxine administration. Nutrition research, 2015. 
[50] Malouf, R.; Grimley Evans, J., The effect of vitamin B6 on cognition. The Cochrane database of 
 systematic reviews, 2003, (4), CD004393. 
[51] Miyake, Y.; Sasaki, S.; Tanaka, K.; Yokoyama, T.; Ohya, Y.; Fukushima, W.; Saito, K.; Ohfuji, S.; 
 Kiyohara, C.; Hirota, Y.; Osaka, M.; Child Health Study, G., Dietary folate and vitamins B12, B6, 
 and B2 intake and the risk of postpartum depression in Japan: the Osaka Maternal and Child 
 Health Study. Journal of affective disorders, 2006, 96, (1-2), 133-138. 
[52] Wang, H.S.; Kuo, M.F., Vitamin B6 related epilepsy during childhood. Chang Gung medical 
 journal, 2007, 30, (5), 396-401. 
[53] General, I.J.; Dragomirova, R.; Meirovitch, H., Absolute free energy of binding of avidin/biotin, 
 revisited. The journal of physical chemistry. B, 2012, 116, (23), 6628-6636. 
[54] Levenson, J.L., Biotin-responsive depression during hyperalimentation. JPEN. Journal of 
 parenteral and enteral nutrition, 1983, 7, (2), 181-183. 
[55] Staggs, C.G.; Sealey, W.M.; McCabe, B.J.; Teague, A.M.; Mock, D.M., Determination of the biotin 
 content of select foods using accurate and sensitive HPLC/avidin binding. Journal of food 
 composition and analysis : an official publication of the United Nations University, International 
 Network of Food Data Systems, 2004, 17, (6), 767-776. 
[56] Zempleni, J.; Mock, D.M., Uptake and metabolism of biotin by human peripheral blood 
 mononuclear cells. The American journal of physiology, 1998, 275, (2 Pt 1), C382-388. 
[57] Bottiglieri, T., Homocysteine and folate metabolism in depression. Progress in neuro-
 psychopharmacology & biological psychiatry, 2005, 29, (7), 1103-1112. 
[58] Bottiglieri, T.; Laundy, M.; Crellin, R.; Toone, B.K.; Carney, M.W.; Reynolds, E.H., Homocysteine, 
 folate, methylation, and monoamine metabolism in depression. Journal of neurology, 
 neurosurgery, and psychiatry, 2000, 69, (2), 228-232. 
[59] Eussen, S.J.; de Groot, L.C.; Joosten, L.W.; Bloo, R.J.; Clarke, R.; Ueland, P.M.; Schneede, J.; 
 Blom, H.J.; Hoefnagels, W.H.; van Staveren, W.A., Effect of oral vitamin B-12 with or without folic 
 acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, 
 placebo-controlled trial. The American journal of clinical nutrition, 2006, 84, (2), 361-370. 
[60] Khaire, A.; Rathod, R.; Kale, A.; Joshi, S., Vitamin B12 and omega-3 fatty acids together regulate 
 lipid metabolism in Wistar rats. Prostaglandins, leukotrienes, and essential fatty acids, 2015, 99, 
 7-17. 
[61] Kikuchi, M.; Kashii, S.; Honda, Y.; Tamura, Y.; Kaneda, K.; Akaike, A., Protective effects of 
 methylcobalamin, a vitamin B12 analog, against glutamate-induced neurotoxicity in retinal cell 
 culture. Investigative ophthalmology & visual science, 1997, 38, (5), 848-854. 
[62] O'Leary, F.; Samman, S., Vitamin B12 in health and disease. Nutrients, 2010, 2, (3), 299-316. 
[63] Reynolds, E., Vitamin B12, folic acid, and the nervous system. The Lancet. Neurology, 2006, 5, 
 (11), 949-960. 
[64] Yasko, A., Nutrigenomics and the methylation cycle. 
 http://www.dramyyasko.com/resources/autism-pathways-to-recovery/chapter-2/, 2015 
[65] Chang, H.H.; Lin, D.P.; Chen, Y.S.; Liu, H.J.; Lin, W.; Tsao, Z.J.; Teng, M.C.; Chen, B.Y., 
 Intravitreal homocysteine-thiolactone injection leads to the degeneration of multiple retinal cells, 
 including photoreceptors. Molecular vision, 2011, 17, 1946-1956. 
[66] Jakubowski, H., Pathophysiological consequences of homocysteine excess. The Journal of 
 nutrition, 2006, 136, (6 Suppl), 1741S-1749S. 
 [67] Obeid, R.; Herrmann, W., Mechanisms of homocysteine neurotoxicity in neurodegenerative 
 diseases with special reference to dementia. FEBS letters, 2006, 580, (13), 2994-3005. 
[68] Pitkin, R.M., Folate and neural tube defects. The American journal of clinical nutrition, 2007, 85, 
 (1), 285S-288S. 
[69] Miller, A.L., The methylation, neurotransmitter, and antioxidant connections between folate and 
 depression. Alternative medicine review : a journal of clinical therapeutic, 2008, 13, (3), 216-226. 
[70] Fava, M.; Mischoulon, D., Folate in depression: efficacy, safety, differences in formulations, and 
 clinical issues. The Journal of clinical psychiatry, 2009, 70 Suppl 5, 12-17. 
[71] Herbison, C.E.; Hickling, S.; Allen, K.L.; O'Sullivan, T.A.; Robinson, M.; Bremner, A.P.; Huang, 
 R.C.; Beilin, L.J.; Mori, T.A.; Oddy, W.H., Low intake of B-vitamins is associated with poor 
 adolescent mental health and behaviour. Preventive medicine, 2012, 55, (6), 634-638. 
[72] Combs, G.F. The Vitamins: Fundamental Aspects in Nutyrition and Health Elsevier: San Diego 
 2008. 
[73] Shils ME, O.J., Shike M et al. Modern Nutrition in Health and Disease 9th edition ed. Lippincott 
 Williams and Wilkins Baltimore, 1999. 
[74] Pepersack, T.; Garbusinski, J.; Robberecht, J.; Beyer, I.; Willems, D.; Fuss, M., Clinical relevance 
 of thiamine status amongst hospitalized elderly patients. Gerontology, 1999, 45, (2), 96-101. 
[75] Friedmann, N.; Rusou, D., Critical period for first language: the crucial role of language input 
 during the first year of life. Current opinion in neurobiology, 2015, 35, 27-34. 
[76] Matthews, B.R., Memory dysfunction. Continuum, 2015, 21, (3 Behavioral Neurology and 
 Neuropsychiatry), 613-626. 
[77] Maiya, R.P.; Messing, R.O., Peripheral systems: neuropathy. Handbook of clinical neurology, 
 2014, 125, 513-525. 
[78] Smidt, L.J.; Cremin, F.M.; Grivetti, L.E.; Clifford, A.J., Influence of thiamin supplementation on the 
 health and general well-being of an elderly Irish population with marginal thiamin deficiency. 
 Journal of gerontology, 1991, 46, (1), M16-22. 
[79] Jong Baw, P.G.; van Veen, M.M.; Hoek, H.W., [Thiamine deficiency caused by malnutrition: a 
 rare cause?]. Tijdschrift voor psychiatrie, 2008, 50, (9), 611-615. 
[80] Nikseresht, S.; Etebary, S.; Karimian, M.; Nabavizadeh, F.; Zarrindast, M.R.; Sadeghipour, H.R., 
 Acute administration of Zn, Mg, and thiamine improves postpartum depression conditions in mice. 
 Archives of Iranian medicine, 2012, 15, (5), 306-311. 
[81] Sheraz, M.A.; Kazi, S.H.; Ahmed, S.; Anwar, Z.; Ahmad, I., Photo, thermal and chemical 
 degradation of riboflavin. Beilstein journal of organic chemistry, 2014, 10, 1999-2012. 
[82] ter Borg, S.; Verlaan, S.; Hemsworth, J.; Mijnarends, D.M.; Schols, J.M.; Luiking, Y.C.; de Groot, 
 L.C., Micronutrient intakes and potential inadequacies of community-dwelling older adults: a 
 systematic review. The British journal of nutrition, 2015, 113, (8), 1195-1206. 
[83] Pinto, J.T.; Cooper, A.J., From cholesterogenesis to steroidogenesis: role of riboflavin and 
 flavoenzymes in the biosynthesis of vitamin D. Advances in nutrition, 2014, 5, (2), 144-163. 
[84] Prakash, R.; Gandotra, S.; Singh, L.K.; Das, B.; Lakra, A., Rapid resolution of delusional 
 parasitosis in pellagra with niacin augmentation therapy. General hospital psychiatry, 2008, 30, 
 (6), 581-584. 
[85] Smesny, S.; Baur, K.; Rudolph, N.; Nenadic, I.; Sauer, H., Alterations of niacin skin sensitivity in 
 recurrent unipolar depressive disorder. Journal of affective disorders, 2010, 124, (3), 335-340. 
[86] Lodish H, B.A., Zipursky SL, et al Molecular cell biology. . 4th ed. W.H. Freeman: New York, 
 2000. 
[87] Hollenbeck, C.B., An introduction to the nutrition and metabolism of choline. Central nervous 
 system agents in medicinal chemistry, 2012, 12, (2), 100-113. 
[88] Zeisel, S.H., Choline: an important nutrient in brain development, liver function and 
 carcinogenesis. Journal of the American College of Nutrition, 1992, 11, (5), 473-481. 
[89] Steingard, R.J.; Yurgelun-Todd, D.A.; Hennen, J.; Moore, J.C.; Moore, C.M.; Vakili, K.; Young, 
 A.D.; Katic, A.; Beardslee, W.R.; Renshaw, P.F., Increased orbitofrontal cortex levels of choline in 
 depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy. 
 Biological psychiatry, 2000, 48, (11), 1053-1061. 
[90] Bjelland, I.; Tell, G.S.; Vollset, S.E.; Konstantinova, S.; Ueland, P.M., Choline in anxiety and 
 depression: the Hordaland Health Study. The American journal of clinical nutrition, 2009, 90, (4), 
 1056-1060. 
 [91] Glenn, M.J.; Adams, R.S.; McClurg, L., Supplemental dietary choline during development exerts 
 antidepressant-like effects in adult female rats. Brain research, 2012, 1443, 52-63. 
[92] Jansen, P.A.; Hermkens, P.H.; Zeeuwen, P.L.; Botman, P.N.; Blaauw, R.H.; Burghout, P.; van 
 Galen, P.M.; Mouton, J.W.; Rutjes, F.P.; Schalkwijk, J., Combination of pantothenamides with 
 vanin inhibitors as a novel antibiotic strategy against gram-positive bacteria. Antimicrobial agents 
 and chemotherapy, 2013, 57, (10), 4794-4800. 
[93] Spry, C.; Macuamule, C.; Lin, Z.; Virga, K.G.; Lee, R.E.; Strauss, E.; Saliba, K.J., 
 Pantothenamides are potent, on-target inhibitors of Plasmodium falciparum growth when serum 
 pantetheinase is inactivated. PloS one, 2013, 8, (2), e54974. 
[94] Huang, S.; Zhang, J.; Wang, L.; Huang, L., Effect of abiotic stress on the abundance of different 
 vitamin B6 vitamers in tobacco plants. Plant physiology and biochemistry : PPB / Societe 
 francaise de physiologie vegetale, 2013, 66, 63-67. 
[95] Middleton, H.M., 3rd, Intestinal hydrolysis of pyridoxal 5'-phosphate in vitro and in vivo in the rat. 
 Effect of protein binding and pH. Gastroenterology, 1986, 91, (2), 343-350. 
[96] Hvas, A.M.; Juul, S.; Bech, P.; Nexo, E., Vitamin B6 level is associated with symptoms of 
 depression. Psychotherapy and psychosomatics, 2004, 73, (6), 340-343. 
[97] Shiloh, R.; Weizman, A.; Weizer, N.; Dorfman-Etrog, P.; Munitz, H., [Antidepressive effect of 
 pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor 
 depression--preliminary open-label trial]. Harefuah, 2001, 140, (5), 369-373, 456. 
[98] Potter, M.C.; Wozniak, K.M.; Callizot, N.; Slusher, B.S., Glutamate carboxypeptidase II inhibition 
 behaviorally and physiologically improves pyridoxine-induced neuropathy in rats. PloS one, 2014, 
 9, (9), e102936. 
[99] Niciu, M.J.; Kelmendi, B.; Sanacora, G., Overview of glutamatergic neurotransmission in the 
 nervous system. Pharmacology, biochemistry, and behavior, 2012, 100, (4), 656-664. 
[100] Seigel, A. Essential Neuroscience second ed. Lippincott Williams and Wilkins Baltimore MD, 
 2011. 
[101] AustralianGovernment, Nutrient Reference Values for Australia and New Zealand 2015. 
[102] Schmitt, A.; Falkai, P., Classification and neurobiological concepts of mania, bipolar disorder and 
 major depression. European archives of psychiatry and clinical neuroscience, 2015, 265, (4), 
 271-272. 
[103] Sanacora, G.; Gueorguieva, R.; Epperson, C.N.; Wu, Y.T.; Appel, M.; Rothman, D.L.; Krystal, 
 J.H.; Mason, G.F., Subtype-specific alterations of gamma-aminobutyric acid and glutamate in 
 patients with major depression. Archives of general psychiatry, 2004, 61, (7), 705-713. 
[104] Paul, I.A.; Skolnick, P., Glutamate and depression: clinical and preclinical studies. Annals of the 
 New York Academy of Sciences, 2003, 1003, 250-272. 
[105] Modi, S.; Rana, P.; Kaur, P.; Rani, N.; Khushu, S., Glutamate level in anterior cingulate predicts 
 anxiety in healthy humans: a magnetic resonance spectroscopy study. Psychiatry research, 2014, 
 224, (1), 34-41. 
[106] Scicurious, Depression  post 4- The Serotonin System. 
 http://scicurious.scientopia.org/2010/08/25/back-to-basics-3-depression-post-4-the-serotonin-
 system/, 2015. 
[107] Mann, J.J., Role of the serotonergic system in the pathogenesis of major depression and suicidal 
 behavior. Neuropsychopharmacology : official publication of the American College of 
 Neuropsychopharmacology, 1999, 21, (2 Suppl), 99S-105S. 
[108] Tork, I., Anatomy of the serotonergic system. Annals of the New York Academy of Sciences, 
 1990, 600, 9-34; discussion 34-35. 
[109] Mulinari, S., Monoamine theories of depression: historical impact on biomedical research. Journal 
 of the history of the neurosciences, 2012, 21, (4), 366-392. 
[110] Olfson, M.; Marcus, S.C., National patterns in antidepressant medication treatment. Archives of 
 general psychiatry, 2009, 66, (8), 848-856. 
[111] Shabbir, F.; Patel, A.; Mattison, C.; Bose, S.; Krishnamohan, R.; Sweeney, E.; Sandhu, S.; Nel, 
 W.; Rais, A.; Sandhu, R.; Ngu, N.; Sharma, S., Effect of diet on serotonergic neurotransmission in 
 depression. Neurochemistry international, 2013, 62, (3), 324-329. 
[112] Ebesunun, M.O.; Eruvulobi, H.U.; Olagunju, T.; Owoeye, O.A., Elevated plasma homocysteine in 
 association with decreased vitamin B(12), folate, serotonin, lipids and lipoproteins in depressed 
 patients. African journal of psychiatry, 2012, 15, (1), 25-29. 
 [113] Kiykim, E.; Kiykim, A.; Cansever, M.S.; Zeybek, C.A., Biotinidase deficiency mimicking primary 
 immune deficiencies. BMJ case reports, 2015, 2015. 
[114] Gilbody, S.; Lightfoot, T.; Sheldon, T., Is low folate a risk factor for depression? A meta-analysis 
 and exploration of heterogeneity. Journal of epidemiology and community health, 2007, 61, (7), 
 631-637. 
[115] Coppen, A.; Bolander-Gouaille, C., Treatment of depression: time to consider folic acid and 
 vitamin B12. Journal of psychopharmacology, 2005, 19, (1), 59-65. 
[116] Tolmunen, T.; Voutilainen, S.; Hintikka, J.; Rissanen, T.; Tanskanen, A.; Viinamaki, H.; Kaplan, 
 G.A.; Salonen, J.T., Dietary folate and depressive symptoms are associated in middle-aged 
 Finnish men. The Journal of nutrition, 2003, 133, (10), 3233-3236. 
[117] Almeida, O.P.; Ford, A.H.; Flicker, L., Systematic review and meta-analysis of randomized 
 placebo-controlled trials of folate and vitamin B12 for depression. International psychogeriatrics / 
 IPA, 2015, 27, (5), 727-737. 
[118] Sengul, O.; Uygur, D.; Gulec, M.; Dilbaz, B.; Simsek, E.M.; Goktolga, U., The comparison of 
folate  and vitamin B12 levels between depressive and nondepressive postmenopausal women. Turkish 
 journal of medical sciences, 2014, 44, (4), 611-615. 
[119] Eisenhofer, G.; Kopin, I.J.; Goldstein, D.S., Catecholamine metabolism: a contemporary view with 
 implications for physiology and medicine. Pharmacological reviews, 2004, 56, (3), 331-349. 
[120] Seamans, J., Dopamine anatomy. http://www.scholarpedia.org/article/Dopamine_anatomy, 2015. 
[121] Dunne, N., Disentangling the dopaminergic system. 
 http://www.feinberg.northwestern.edu/news/2014/12/Awatramani-dopamine.html, 2015. 
[122] Jones, S. Dopamine-glutamate Interactions in the Basal Ganglia CRC Press- Taylor and Francis 
 group: Parkway NW, 2012. 
[123] Yadid, G.; Friedman, A., Dynamics of the dopaminergic system as a key component to the 
 understanding of depression. Progress in brain research, 2008, 172, 265-286. 
[124] Kapur, S.; Mann, J.J., Role of the dopaminergic system in depression. Biological psychiatry, 
 1992, 32, (1), 1-17. 
[125] van Enkhuizen, J.; Milienne-Petiot, M.; Geyer, M.A.; Young, J.W., Modeling bipolar disorder in 
 mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features. 
 Psychopharmacology, 2015. 
[126] Juzeniene, A.; Nizauskaite, Z., Photodegradation of cobalamins in aqueous solutions and in 
 human blood. Journal of photochemistry and photobiology. B, Biology, 2013, 122, 7-14. 
[127] Marks, A.D. Basic Medical Biochemistry: A clinical Approach 3rd edition ed. Lippincott Williams 
 and Wilkins 2009. 
[128] Majumder, S.; Soriano, J.; Louie Cruz, A.; Dasanu, C.A., Vitamin B12 deficiency in patients 
 undergoing bariatric surgery: preventive strategies and key recommendations. Surgery for obesity 
 and related diseases : official journal of the American Society for Bariatric Surgery, 2013, 9, (6), 
 1013-1019. 
[129] Carvalho, I.R.; Loscalzo, I.T.; Freitas, M.F.; Jordao, R.E.; Friano Tde, C., Incidence of vitamin 
 B12 deficiency in patients submitted to Fobi-Capella Roux-en-Y bariatric surgery. Arquivos 
 brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery, 2012, 25, (1), 
 36-40. 
[130] Pawlak, R.; Lester, S.E.; Babatunde, T., The prevalence of cobalamin deficiency among 
 vegetarians assessed by serum vitamin B12: a review of literature. European journal of clinical 
 nutrition, 2014, 68, (5), 541-548. 
[131] Vogiatzoglou, A.; Refsum, H.; Johnston, C.; Smith, S.M.; Bradley, K.M.; de Jager, C.; Budge, 
 M.M.; Smith, A.D., Vitamin B12 status and rate of brain volume loss in community-dwelling 
 elderly. Neurology, 2008, 71, (11), 826-832. 
[132] Seppala, J.; Koponen, H.; Kautiainen, H.; Eriksson, J.G.; Kampman, O.; Leiviska, J.; Mannisto, 
 S.; Mantyselka, P.; Oksa, H.; Ovaskainen, Y.; Viikki, M.; Vanhala, M.; Seppala, J., Association 
 between vitamin b12 levels and melancholic depressive symptoms: a Finnish population-based 
 study. BMC psychiatry, 2013, 13, 145. 
[133] Permoda-Osip, A.; Dorszewska, J.; Skibinska, M.; Chlopocka-Wozniak, M.; Rybakowski, J.K., 
 Hyperhomocysteinemia in bipolar depression: clinical and biochemical correlates. 
 Neuropsychobiology, 2013, 68, (4), 193-196. 
 [134] Bell, I.R.; Edman, J.S.; Morrow, F.D.; Marby, D.W.; Mirages, S.; Perrone, G.; Kayne, H.L.; Cole, 
 J.O., B complex vitamin patterns in geriatric and young adult inpatients with major depression. 
 Journal of the American Geriatrics Society, 1991, 39, (3), 252-257. 
[135] Gougeon, L., Nutritional predictors of depression in a cohort of community-dwelling elderly 
 Canadians: NuAge cohort. Applied physiology, nutrition, and metabolism = Physiologie 
appliquee,  nutrition et metabolisme, 2014, 39, (12), 1412. 
[136] Syed, E.U.; Wasay, M.; Awan, S., Vitamin B12 supplementation in treating major depressive 
 disorder: a randomized controlled trial. The open neurology journal, 2013, 7, 44-48. 
[137] Walker, J.G.; Batterham, P.J.; Mackinnon, A.J.; Jorm, A.F.; Hickie, I.; Fenech, M.; Kljakovic, M.; 
 Crisp, D.; Christensen, H., Oral folic acid and vitamin B-12 supplementation to prevent cognitive 
 decline in community-dwelling older adults with depressive symptoms--the Beyond Ageing 
 Project: a randomized controlled trial. The American journal of clinical nutrition, 2012, 95, (1), 
 194-203. 
[138] Ressler, K.J.; Nemeroff, C.B., Role of serotonergic and noradrenergic systems in the 
 pathophysiology of depression and anxiety disorders. Depression and anxiety, 2000, 12 Suppl 1, 
 2-19. 
[139] van Stegeren, A.H., The role of the noradrenergic system in emotional memory. Acta 
 psychologica, 2008, 127, (3), 532-541. 
[140] Pavlin, M.; Repic, M.; Vianello, R.; Mavri, J., The Chemistry of Neurodegeneration: Kinetic Data 
 and Their Implications. Molecular neurobiology, 2015. 
[141] Kuffel, A.; Eikelmann, S.; Terfehr, K.; Mau, G.; Kuehl, L.K.; Otte, C.; Lowe, B.; Spitzer, C.; 
 Wingenfeld, K., Noradrenergic blockade and memory in patients with major depression and 
 healthy participants. Psychoneuroendocrinology, 2014, 40, 86-90. 
[142] Lang, U.E.; Borgwardt, S., Molecular mechanisms of depression: perspectives on new treatment 
 strategies. Cellular physiology and biochemistry : international journal of experimental cellular 
 physiology, biochemistry, and pharmacology, 2013, 31, (6), 761-777. 
[143] Weinberger, J.F.; Raison, C.L.; Rye, D.B.; Montague, A.R.; Woolwine, B.J.; Felger, J.C.; Haroon, 
 E.; Miller, A.H., Inhibition of tumor necrosis factor improves sleep continuity in patients with 
 treatment resistant depression and high inflammation. Brain, behavior, and immunity, 2014. 
[144] Tizabi, Y.; Hurley, L.L.; Qualls, Z.; Akinfiresoye, L., Relevance of the Anti-Inflammatory Properties 
 of Curcumin in Neurodegenerative Diseases and Depression. Molecules, 2014, 19, (12), 20864-
 20879. 
[145] Au, B.; Smith, K.J.; Gariepy, G.; Schmitz, N., The longitudinal associations between C-reactive 
 protein and depressive symptoms: evidence from the English Longitudinal Study of Ageing 
 (ELSA). International journal of geriatric psychiatry, 2014. 
[146] Black, C.; Miller, B.J., Meta-analysis of Cytokines and Chemokines in Suicidality: Distinguishing 






Fig. (1). Relationship between vitamin B and neurochemical pathways leading to depression (and 




 Table 1. B Vitamins as co-enzymes.  
B Vitamin  Co-Enzyme Enzyme Chemical group 
transferred  







Aldehydes  • Part of co-enzyme thiamin 
pyrophosphate,  
• decarboxylation of pyruvic and α-
ketoglutarate acids,  
• utilization of pentose in the hexose 
monophosphate shunt.  
• Aids the conversion of pyruvate to acetyl 
CoA in the pyruvate dehydrogenase 
complex 
• Plays a part in the α-ketoglutarate-
dehydrogenase complex in the TCA 
(Krebs) cycle, converting a 5 carbon 
compound to a 4 carbon compound.  
• catabolism of branched-chain amino 










Electrons   
• FAD forms part of the complex II of the 
electron transport chain,  
• FAD essential in the conversion of 
pyridoxal (Vitamin B6) to pyridoxic acid 
by pyridoxine 5’ phosphate oxidase  
• FAD aids conversion of retinol to retinoic 
acid via retinal dehydrogenase.  
• FAD is also necessary for oxidating 
pyruvate, a-ketoglutarate and branched 
chain amino acids 
• FAD reduces the oxidized form of 
glutathione to glutathione reductase in 
complex II of the electron transport 
chain.  
• Fatty acyl Co-a dehydrogenase requires 
FAD in fatty acid oxidation and FADH2 
synthesizes an active form of folate (5- 
mehtyltetrahydrofolate) from 5,10-
methylenetetrahydrofolate.  
• FMN is an important component in the 
primary coenzyme form of Vitamin B6 
and required to convert tryptophan to 
niacin (Vitamin B3) in complex I of the 
electron transport chain.  
• FMN reduces the oxidized form of 
glutathione to glutathione reductase in 
complex II of the electron transport 
chain 






dehydrogenase Hydride ion (:H
-
) 
• The enzyme NAD+ kinase 
phosphorylates NAD to NADPH, both 
acting as coenzymes for many 
dehydrogenases which participate in 
hydrogen transfer processes.  
• NAD is a significant contributor to the 
catabolism of fat, carbohydrate, protein, 
and alcohol,  
• NADP mostly occurs in anabolistic 
reactions such as fatty acid and 
cholesterol synthesis.  
 • NAD is required for cell signalling and 
DNA repair 






Acyl groups • Acyl group carrier to form acetyl-CoA 
and other related compounds;   
• Energy metabolism for pyruvate to enter  
TCA as acetyl-CoA,  
• Ketoglutarate to be transformed to 
succinyl-CoA in the cycle. 
• Biosynthesis of fatty acids, cholesterol, 
and acetylcholine.  
• Formation of acyl carrier protein,  
• Acylation and Acetylation involved in 
signal transduction and enzyme 
activation and deactivation, respectively.  






Amino groups • Cofactor in the biosynthesis of 
serotonin, dopamine, epinephrine, 
norepinephrine, gamma-amino butyric 
acid  
• Synthesis of histamine. 
• Co-factor for amino acid breakdown and 
moving amine groups from one amino 
acid to another. 
• Aids serine racemase to synthesize 
serine ( a neuromodulator)  
• Helps  transform methionine into 
cysteine. 
• Helps transform selenomethionine to 
selenium.  
• Releases selenium from 
selenohomocysteine to produce 
hydrogen selenide, which can then be 
used to incorporate selenium into 
selenoproteins. 
• Conversion of tryptophan to niacin. 





CO2 • Acetyl-CoA carboxylase alpha 
• Acetyl-CoA carboxylase beta 
• Methylcrotonyl-CoA carboxylase 
• Propionyl-CoA carboxylase 
• Pyruvate carboxylase 
• Gluconeogenesis, fatty acid synthesis, 





one carbon groups •  (THF) and other folate derivatives  
important in a series of single carbon 
transfer reactions.  
• Important in methylation along with B12 
and B6 for recycling homocysteine into 
methionine.  
 • Synthesis of DNA and the process of 
cell division.  
• Folate in the form of 5-MTHF helps to 
regulate neurotransmission of 
monoamines.  
• DNA methylation.  










H atoms and alkyl groups  • Metabolism of carbohydrates, protein 
and fat.  
• Co-factor for fatty acid elongation 
• Participates in Isomerase and 
Methyltransferase reactions.  
• MUT converts L-methylmalonyl Co-A to 
Succinyl Co-A before it enters the citric 
acid cycle. 
•  MTR uses B12 as a cofactor to transfer 
a methyl group from 5-MTHFR to 
homocysteine to generate THF and 
methionine used in the methylation 
cycle.  
 
 Table 2. B Vitamins: Function, Deficiency, Sources 
 
B Vitamin Function  Deficiency Symptoms Deficiency 




-Generation of nerve impulses 
-Synthesis of neurotransmitters, 
nucleic acids,  




-Cardiac failure  
-muscular weakness 
 -apathy 




-anorexia, weight loss. -
Depressive symptoms 





Whole grain fortified or enriched 
grain products. pork, contained in 




-Co-Enzyme in many reactions.  
-Energy Metabolism in the forms-  
  flavin mononucleotide 
 flavin adeninedinucleotide 
-inflammation of 
membranes of mouth, skin, 
eyes and gastrointestinal 
tract.  
-Poor cognitive outcomes  
Ariboflavinosis  Milk products, wholegrain fortified 





Part of  co-enzyme NAD. Can be 




- abdominal pain, vomiting, 
inflamed swollen smooth 
bright red tongue, 
(glossitis),  
-depression, apathy, 
fatigue, memory loss 
headache, bilateral 
symmetrical rash on areas 
exposed to sunlight.  
-Depressive symptoms 
Pellagra  Milk, eggs, meat, poultry, fish, 
wholegrain, fortified and enriched 
grain products, nuts and all 
protein containing foods.  
 Choline 
 




 Milk, liver. eggs. Peanuts, wheat 
germ. 
Also synthesized endogenously 
by renal medullar cells 
Vitamin B5 Pantothenic 
Acid 
-Part of chemical structure of 
coenzyme A.  
-Important for TCA (Krebs) cycle 
in energy metabolism, fat 
synthesis, amino acid 
metabolism, glycogen synthesis.  
synthesis of steroid hormones, 
melatonin and acetylcholine. 
Vomiting, nausea, stomach 




sensitivity to insulin, 
numbness, muscle cramps, 










Chicken, beef, potatoes, oats, 
tomatoes, liver, egg yolk, 
broccoli, wholegrain  
Vitamin B6 -Energy metabolism as Fatigue, Gastrointestinal  Meats, fish, poultry, potatoes and 
 B Vitamin Function  Deficiency Symptoms Deficiency 
Diseases   
Sources  
Pyridoxine 
Pyridoxal, pyridoxamine  
(all forms can be 









coenzyme A  
-Cognitive performance 
 -Immune function, 
- Steroid hormone activity 
 - Aids conversion of tryptophan 
to niacin or serotonin.  
-Synthesis of GABA, dopamine, 




confusion and seizures) 
 -Depressive symptoms 
other starchy vegetables, 
legumes, non citrus fruits, 





Energy metabolism Carries 
activated CO2 which in TCA 
(Krebs) cycle turns pyruvate into 
oxaloacetate and combines with 
Acetyl CoA.    
Gluconeogenesis and fatty acid 
synthesis and breakdown. 
Biotin is the isomer of B2 
complex 
Lethargy, hallucinations, 
numb or tingling sensation 
in the arms and legs, red 
scaly rash around the eyes 
nose and mouth, hair loss  
 Liver, egg yolks, soy beans, fish, 
whole grains, also produced by 
gut flora  
Vitamin B9 
Folate 
Folic acid  
Folacin 
DNA synthesis and new cell 
formation. Tetrahydrofolate in its 
primary co enzyme form 
facilitates transfer of one carbon 
compounds during metabolism.  
Aids conversion of B12 to a 
conenzyme form. 
synthesis of norepinephrine, 
dopamine, and serotonin. 
Breakdown of norepinephrine 
and dopamine    
Smooth red tongue, mental 
confusion, weakness, 
fatigue, irritability, 





Neural tube Defect 
in foetus. 
Fortified grains, leafy green 
vegetables, legumes, seeds, liver  
Vitamin B12 
(Cobalamine) 
Synthesis of new cells, nerve cell 
maintenance, reforms folate 
coenxyme, helps break down 
fatty acids and amino acids. 
A close relationship exists 
between folate and B12 each 
depends on the other for 
activation. B12 removes a methyl 
group and activates folate 
coenzyme. The removal of the 
methyl group from B12 activates 
cB12 co-enzyme  
Anaemia (large cell type), 
fatigue, degeneration of 
peripheral nerves 
progressing to paralysis, 














Foods of animal origin, meat, 
fish, poultry, shellfish, milk, 





Table 3. B Vitamins: Structure, binding, absorption, metabolism and excretion.  
 






Serum proteins  
mainly albumin 
Low concentrations by 
passive transport in 
upper small intestine. 
Low concentrations by 
active transport 
mostly in jejunum and 
ileum   
~ 80 % is 
phosphorylated 
and most is 
bound to proteins  
Urine as thiamin and acid 
metabolites (2-methyl-4-amino-
5-pyrimidine carboxylic acid, 4-
methyl-thiazole-5-acetic acid, 




Free B2 binds to 
albumin and certain 
immunoglobulin’s  
Upper part of small 
intestine best 
absorbed when taken 
with food (60% versus 
15% with no food) 




. Free riboflavin is 
diffused from 
cells and excreted 














stomach and small 
intestine 
stored in liver 







In urine as N1-methyl-









Capable of forming 
phosphoester bonds 
(Phosphocholines.) 
Acetyl group from 
Acetyl CoA binds to 
choline to create 
Acetylcholine. 
This process is 
catalyzed by 
acetyltransferase 








Once absorbed enters 
portal system and 
taken up by liver 
Three systems for 
uptake. 
Facilitated 
transport in red 




Low affinity high 
capacity active 




Reabsorbed by renal tubules 
when levels are normal. When 
levels are above normal choline 
is actively excreted by renal 
tubules 







Bound to proteins as 
acyl carrier protein 
Absorbed in small 
intestine by active 
transport at low 
concentrations  
passive transport at 
high concentrations  
Found in food as 
CoA or acyl carrier 
protein must be 
covered to free 
pantothenic acid 
before absorption 
can take place in 
intestinal cells 
Excreted intact in the urine 






















and Pyridoxamine are 
converted to 
metabolically active 
form of pyridoxal 
phosphate. 
This conversion is 
catalyzed by pyridoxal 
kinase and requires zinc 
for full activation  
Absorbed in jejunum 
and ileum by passive 
diffusion 
Dephosphorylatio




catalyzed by an 
alkaline 
phosphatase  
Excreted in urine mostly as 4-
pyridoxic acid 
when vitamin B6 levels are high 
pyridoxal, pyridoxamine,  
pyridoxine and their phosphates 
are also excreted. A small 
amount of B6 is excreted in the 
faeces  
 




Dietary biotin binds to 
dietary avdin and 
prevents its absorption 




Pteridine ring linked to 
benzoic acid 
Epithelial cells of 
intestine into blood 
stream  
this is done after 









Excreted in urine 






Bound to protein in 
food. 
Released by HCL and 
gastric proteases 
B12 combines with 
intrinsic factor and is 
absorbed in ileum. 
Absorption reliant on 
the capacity of 
intrinsic factor. In 
healthy people only 
1mcg of a 500mcg oral 
supplement is actually 
absorbed   
 
 




B12 complex and 
the free B12 is 
released into the 
cytoplasm 
 
Main source of excretion via bile 
but most of this is reabsorbed 
via enterohepatic circulation 
and stored in liver with only a 
small amount entereing faeces. 
Higher amounts are excreted in 
the urine  
 
 
 
 
 
